Eribulin Mesylate 0.5mg/mL, 2mL Injection

Eribulin Mesylate 0.5mg/mL, 2mL is a microtubule inhibitor used for selected advanced breast cancers and liposarcoma.
The calculated dose is injected intravenously on specified treatment days within a repeating cycle. Blood counts, liver function and existing neuropathy influence further doses.
Eribulin blocks microtubule growth, disrupting mitotic spindle formation and leading to cancer-cell death.
Low white-cell counts, tiredness, hair loss, nausea, constipation and peripheral neuropathy can occur. Fever during neutropenia requires urgent assessment.
New numbness or weakness should be reported early. Electrolyte abnormalities and heart-rhythm risk are considered when QT-prolonging medicines are also used.
Can slow progression in eligible cancers after the relevant prior treatments.
Low neutrophils can make another dose unsafe and increase serious infection risk.
Yes. Peripheral neuropathy can worsen with continuing exposure and may require an interruption or adjustment.
No. Eribulin is given on designated days with recovery time between cycles.
Impaired liver handling can increase exposure and toxicity.
Microtubule: part of the cell-division scaffold. Neutropenia: a low neutrophil count. Liposarcoma: a cancer of fat-forming tissue.; AR: Eribulin Mesylate 0.5mg/mL, 2mL حقن; FR: Eribulin Mesylate 0.5mg/mL, 2mL injection; PT: Eribulin Mesylate 0.5mg/mL, 2mL injeção; ES: Eribulin Mesylate 0.5mg/mL, 2mL inyección; RU: Eribulin Mesylate 0.5mg/mL, 2mL инъекция; ID: Eribulin Mesylate 0.5mg/mL, 2mL injeksi; VI: Eribulin Mesylate 0.5mg/mL, 2mL thuốc tiêm; MS: Eribulin Mesylate 0.5mg/mL, 2mL suntikan; TL: Eribulin Mesylate 0.5mg/mL, 2mL iniksyon; ZH-SG: Eribulin Mesylate 0.5mg/mL, 2mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Eribulin Mesylate 0.5mg/mL, 2mL Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Eribulin Mesylate 0.5mg/mL, 2mL Injection